XML 108 R64.htm IDEA: XBRL DOCUMENT v3.22.4

Other current assets (Tables)

12 Months Ended

Dec. 31, 2022

Subclassifications of assets, liabilities and equities [abstract]

Schedule of Other Current Assets

An analysis of Other current assets is set forth below:

(€ million)			2022			2021			2020
Tax receivables, other than corporate income taxes			658			802			687
Prepaid expenses			714			615			525
Other receivables(a)			1,290			805			567
Interest rate derivatives measured at fair value (see Note D.20.)			—			11			—
Currency derivatives measured at fair value (see Note D.20.)			206			284			58
Other current financial assets(b)			664			1,054			900
Total			3,532			3,571			2,737

(a) This line mainly comprises advance payments to suppliers, and receivables relating to Sanofi's activities as agent under a transitional services agreement.

(b) This item includes bank loans and receivables maturing in less than one year with high-grade counterparties. For 2021, this item also includes debt instruments derived from the acquisitions of Translate Bio and Kadmon (carried out in 2021) with maturities of more than 3 months at inception and less than 12 months at December 31, 2021.

X

- References

No definition available.

+ Details

Name:	ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of detailed information of other current assets.

+ References

No definition available.

+ Details

Name:	sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock
Namespace Prefix:	sny_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration